中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines

文献类型:期刊论文

作者Liu, Jiawei2; Zu, Mian1,3; Chen, Kaotan2; Gao, Li1,3; Min, Huan2; Zhuo, Weiling1,3; Chen, Weiwen2; Liu, Ailin1,3
刊名BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
出版日期2018-03-20
卷号18
ISSN号1472-6882
关键词A (H1N1) influenza virus Neuraminidase inhibitor Anti-influenza agents Medicinal plant Lingnan Chinese medicines
DOI10.1186/s12906-018-2173-1
文献子类Article
英文摘要Background: Neuraminidase (NA) is one of the key surface protein of the influenza virus, and has been established as a primary drug target for anti-influenza therapies. This study aimed to screen bioactive herbal extracts from some medicinal plants traditionally used in Lingnan Chinese Medicines by NA activity high-throughput screening assay. Methods: One hundred ninety herbal extracts from 95 medicinal plants collected in Guangzhou were screened for their potential inhibitory activities against A (H1N1) influenza neuraminidase, and the most active extracts were further evaluated for their anti-influenza virus activities using virus-induced cytopathic effect (CPE). Results: Among the tested 190 herbal extracts, 14 extracts inhibited significantly NA activity (IC50 < 40 mu g/mL), and the extracts 1-5, which were obtained from Amomurn villosum Lour, Melaphis chinensis (Bell) Baker, Sanguisorba officinalis and Flos Caryophylli, showed potent inhibitory activity against NA with IC50 values ranging from 4.1 to 9.6 mu g/mL. Moreover, the most bioactive extracts 1-5 were found to protect MDCK cells from A (H1N1) influenza virus infection with very low cytotoxicity to the host cells (EC50 values ranged from 1.8 to 14.1 mu g/mL, CC50 values ranged from 97.0 to 779.2 mu g/mL, SI values ranged from 14 to 438). In addition, quantitative RT-PCR analysis showed that the extracts 1-5 inhibited viral RNA synthesis in a dose-dependent manner. Conclusion: We performed in vitro screening of anti-neuraminidase activities of herbal extracts from medicinal plants used in Lingnan Chinese Medicines, and the results indicate that some bioactive extracts are worth further studies to identify the bioactive components responsible for anti-influenza virus activities, to elucidate their modes of action and finally determine their clinical potentials.
WOS关键词INFLUENZA-VIRUS NEURAMINIDASE ; SANGUISORBA-OFFICINALIS L. ; ANTIVIRAL ACTIVITIES ; ETHANOL EXTRACT ; OSELTAMIVIR ; FLAVONOIDS ; EMERGENCE ; ZANAMIVIR ; VACCINES ; TARGET
资助项目China National Natural Science Foundation[81373432] ; Guangzhou Science and Technology Program[2014 J4100118] ; National Great Science and Technology Major Projects[2012ZX09301002-2013HXW-11] ; Beijing Natural Science Foundation Grant[7152103]
WOS研究方向Integrative & Complementary Medicine
语种英语
出版者BIOMED CENTRAL LTD
WOS记录号WOS:000428224900007
源URL[http://119.78.100.183/handle/2S10ELR8/279845]  
专题中国科学院上海药物研究所
通讯作者Liu, Jiawei; Liu, Ailin
作者单位1.Chinese Acad Sci, Beijing Key Lab Drug Target Res & Drug Screening, Inst Mat Med, 1 Xian Nong Tan St, Beijing 100050, Peoples R China;
2.Guangzhou Univ Chinese Med, Res Ctr Med Plants Resource Sci & Engn, Key Lab Chinese Med Resource Lingnan, Minist Educ,Higher Educ Mega Ctr, 232 Waihuandong Rd, Guangzhou 510006, Guangdong, Peoples R China;
3.Peking Union Med Coll, 1 Xian Nong Tan St, Beijing 100050, Peoples R China
推荐引用方式
GB/T 7714
Liu, Jiawei,Zu, Mian,Chen, Kaotan,et al. Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines[J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE,2018,18.
APA Liu, Jiawei.,Zu, Mian.,Chen, Kaotan.,Gao, Li.,Min, Huan.,...&Liu, Ailin.(2018).Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines.BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE,18.
MLA Liu, Jiawei,et al."Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines".BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 18(2018).

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。